Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
356.00    3.00 (0.85%)
Bid:
355.00
Ask:
356.50
Spread: 1.50 (0.423%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

24 Jul 2017 17:09

RNS Number : 9347L
Caledonia Investments PLC
24 July 2017
Β 

CALEDONIA INVESTMENTS PLC - GRANT OF SHARE OPTIONS

Pursuant to the requirements of the EU Market Abuse Regulation, Caledonia Investments plc ("Caledonia") announces that on 21 July 2017 the following nil-cost options over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2011 Performance Share Scheme (the "Performance Share Scheme") and in respect of compulsory deferral of bonus under the Caledonia Investments 2011 Deferred Bonus Plan (the "Deferred Bonus Plan"). The company's share price used to determine the number of Performance Share Scheme and Deferred Bonus awards was 2837p.

Executive Director

No. of shares over which Performance Share Scheme nil-cost options granted

No. of shares subject to Deferred Bonus Plan

Β 

J M B Cayzer-Colvin

16,800

5,464

S A King

19,880

6,461

W P Wyatt

27,732

9,016

Subject to the rules of the Performance Share Scheme, nil-cost options are exercisable between three and ten years after the date of grant. Subject to the rules of the Deferred Bonus Plan, deferred share awards vest after a three year retention period.

The total number of awards held by the above-named executive directors of Caledonia under the Performance Share Scheme and the Deferred Bonus Plan following these nil-cost option grants are as follows:

Executive Director

Total no. of shares held under option under the Performance Share Scheme

Total deferred bonus plan share awards

J M B Cayzer-Colvin

75,395

17,944

S A King

89,176

21,219

W P Wyatt

125,128

29,816

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc + 44 20 7802 8080

24 July 2017

Β 

Further information required by the EU Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

APPENDIX

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

James Michael Beale Cayzer-Colvin

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost awards under (1) the Caledonia Investments plc 2011 Performance Share Scheme ("PSS") and (2) the Caledonia Investments plc 2011 Deferred Bonus Plan ("DBP)

c)

Β 

Price(s) and volume(s)

Β 

Β 

1. Grant of PSS awards

Β 

2. Grant of DBP awards

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

16,800

Β 

Β£0.00

5,464

Β 

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Grant of awards 22,264

Β 

Β£0.00

e)

Β 

Date of the transaction

Β 

Β 

21 July 2017

f)

Β 

Place of the transaction

Β 

Β 

Outside a trading venue

Β 

Β 

Β 

APPENDIX

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stephen Anthony King

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost awards under (1) the Caledonia Investments plc 2011 Performance Share Scheme ("PSS") and (2) the Caledonia Investments plc 2011 Deferred Bonus Plan ("DBP)

c)

Β 

Price(s) and volume(s)

Β 

Β 

1. Grant of PSS awards

Β 

2. Grant of DBP awards

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

19,880

Β 

Β£0.00

6,461

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Grant of awards 26,341

Β 

Β£0.00

e)

Β 

Date of the transaction

Β 

Β 

21 July 2017

f)

Β 

Place of the transaction

Β 

Β 

Outside a trading venue

Β 

Β 

Β 

APPENDIX

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

William Penfold Wyatt

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Director

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

Β 

GB0001639920

b)

Β 

Nature of the transaction

Β 

Β 

Grant of nil-cost awards under (1) the Caledonia Investments plc 2011 Performance Share Scheme ("PSS") and (2) the Caledonia Investments plc 2011 Deferred Bonus Plan ("DBP)

c)

Β 

Price(s) and volume(s)

Β 

Β 

1. Grant of PSS awards

Β 

2. Grant of DBP awards

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0.00

Β 

27,732

Β 

Β£0.00

9,016

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Grant of awards 36,748

Β 

Β£0.00

e)

Β 

Date of the transaction

Β 

Β 

21 July 2017

f)

Β 

Place of the transaction

Β 

Β 

Outside a trading venue

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHSEDFMLFWSESW
Date   Source Headline
30th Jun 20215:51 pmRNSTotal Voting Rights
30th Jun 20215:50 pmRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in Own Shares
17th Jun 20215:09 pmRNSAnnual Financial Report
10th Jun 20219:01 amRNSHolding(s) in Company
7th Jun 20214:46 pmRNSDirector/PDMR Shareholding
7th Jun 20214:37 pmRNSDirector/PDMR Shareholding
4th Jun 202111:58 amRNSNet Asset Value(s)
1st Jun 20217:00 amRNSCaledonia Private Capital sells DSE
27th May 20217:00 amRNSFinal Results
7th May 202111:39 amRNSNet Asset Value(s)
6th May 20218:13 amRNSHolding(s) in Company
9th Apr 20219:01 amRNSUnaudited net asset value and portfolio update
25th Mar 20215:45 pmRNSHolding(s) in Company
17th Mar 202110:03 amRNSDisposal
5th Mar 202112:27 pmRNSNet Asset Value(s)
16th Feb 20219:01 amRNSDirector Declaration
4th Feb 20219:11 amRNSNet Asset Value(s)
8th Jan 202110:39 amRNSNet Asset Value and Portfolio Update
7th Dec 202010:50 amRNSNet Asset Value(s)
27th Nov 20207:00 amRNSResult of Audit Tender
24th Nov 20207:00 amRNSHalf-year Report
6th Nov 202010:17 amRNSNet Asset Value(s)
7th Oct 202012:00 pmRNSNet Asset Value(s)
23rd Sep 20203:37 pmRNSDirector/PDMR Shareholding
22nd Sep 20209:13 amRNSHolding(s) in Company
21st Sep 20203:02 pmRNSDirector/PDMR Shareholding
4th Sep 20202:40 pmRNSNet Asset Value(s)
6th Aug 20204:08 pmRNSNet Asset Value(s)
5th Aug 20204:15 pmRNSDirector/PDMR Shareholding
5th Aug 20201:57 pmRNSDirector/PDMR Shareholding
29th Jul 20204:36 pmRNSResult of AGM
15th Jul 202010:52 amRNSPortfolio Update
7th Jul 202010:41 amRNSNet Asset Value(s)
1st Jul 202012:32 pmRNSBlock listing Interim Review
24th Jun 20204:37 pmRNSAnnual Financial Report
5th Jun 20209:05 amRNSNet Asset Value(s)
1st Jun 20205:20 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSFinal Results
19th May 20205:28 pmRNSDirector Declaration
7th May 20209:08 amRNSNet Asset Value(s)
30th Apr 20204:26 pmRNSDirector Declaration
28th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20206:06 pmRNSDisclosure of rights attached to equity shares
7th Apr 20207:00 amRNSNet Asset Value(s)
30th Mar 20203:37 pmRNSHolding(s) in Company
20th Mar 20204:41 pmRNSPrice Monitoring Extension
20th Mar 202010:10 amRNSHolding(s) in Company
5th Mar 202011:24 amRNSNet Asset Value(s)
6th Feb 202010:47 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.